Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience

Detalles Bibliográficos
Autores principales: Park, Jihye, Cheon, Jae Hee, Park, Yehyun, Park, Soo Jung, Kim, Tae Il, Kim, Won Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2018
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934607/
https://www.ncbi.nlm.nih.gov/pubmed/29743847
http://dx.doi.org/10.5217/ir.2018.16.2.315
_version_ 1783320144711254016
author Park, Jihye
Cheon, Jae Hee
Park, Yehyun
Park, Soo Jung
Kim, Tae Il
Kim, Won Ho
author_facet Park, Jihye
Cheon, Jae Hee
Park, Yehyun
Park, Soo Jung
Kim, Tae Il
Kim, Won Ho
author_sort Park, Jihye
collection PubMed
description
format Online
Article
Text
id pubmed-5934607
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Korean Association for the Study of Intestinal Diseases
record_format MEDLINE/PubMed
spelling pubmed-59346072018-05-09 Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience Park, Jihye Cheon, Jae Hee Park, Yehyun Park, Soo Jung Kim, Tae Il Kim, Won Ho Intest Res Brief Communication Korean Association for the Study of Intestinal Diseases 2018-04 2018-04-30 /pmc/articles/PMC5934607/ /pubmed/29743847 http://dx.doi.org/10.5217/ir.2018.16.2.315 Text en © Copyright 2018. Korean Association for the Study of Intestinal Diseases. http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Communication
Park, Jihye
Cheon, Jae Hee
Park, Yehyun
Park, Soo Jung
Kim, Tae Il
Kim, Won Ho
Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience
title Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience
title_full Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience
title_fullStr Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience
title_full_unstemmed Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience
title_short Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience
title_sort efficacy and tolerability of methotrexate therapy for refractory intestinal behçet's disease: a single center experience
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934607/
https://www.ncbi.nlm.nih.gov/pubmed/29743847
http://dx.doi.org/10.5217/ir.2018.16.2.315
work_keys_str_mv AT parkjihye efficacyandtolerabilityofmethotrexatetherapyforrefractoryintestinalbehcetsdiseaseasinglecenterexperience
AT cheonjaehee efficacyandtolerabilityofmethotrexatetherapyforrefractoryintestinalbehcetsdiseaseasinglecenterexperience
AT parkyehyun efficacyandtolerabilityofmethotrexatetherapyforrefractoryintestinalbehcetsdiseaseasinglecenterexperience
AT parksoojung efficacyandtolerabilityofmethotrexatetherapyforrefractoryintestinalbehcetsdiseaseasinglecenterexperience
AT kimtaeil efficacyandtolerabilityofmethotrexatetherapyforrefractoryintestinalbehcetsdiseaseasinglecenterexperience
AT kimwonho efficacyandtolerabilityofmethotrexatetherapyforrefractoryintestinalbehcetsdiseaseasinglecenterexperience

Ejemplares similares